Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.cgh.2023.11.028 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Mesalazine-Induced Obstructive Intrahepatic and Extrahepatic Bile Duct Inflammation Mimicking Cholangiocarcinoma.
Clin Gastroenterol Hepatol
May 2024
Department of Gastroenterology, Herlev Hospital, Herlev, Denmark.
Mesalazine-induced airway obstruction: Utility of pulmonary function testing in drug-induced lung diseases.
Respir Investig
November 2019
Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, 5-1-1 Nabeshima, Saga, Saga Prefecture, 849-8501, Japan.
Mesalazine is a standard therapeutic agent for the treatment of inflammatory bowel diseases. A rare case of mesalazine-induced airway obstruction documented by pulmonary function testing is reported herein. The patient had Crohn's disease and was treated with mesalazine; she subsequently developed a high fever, cough, and chest pain with centrilobular nodular shadows on chest computed tomography (CT).
View Article and Find Full Text PDFLung disease and ulcerative colitis--mesalazine-induced bronchiolitis obliterans with organizing pneumonia or pulmonary manifestation of inflammatory bowel disease?
Z Gastroenterol
September 2015
Clinic of Internal Medicine IV, Jena University Hospital, Jena, Germany.
Ulcerative colitis can be associated with numerous extraintestinal organ manifestations. Pulmonary disease in inflammatory bowel disease (IBD) is supposed to be a rare entity and has to be distinguished from infectious complications and side-effects of medications used in the treatment of IBD. We present the case of a 20-year-old male patient with ulcerative colitis and a 4-week history of respiratory symptoms, malaise, fever and respiratory insufficiency under a medication with mesalazine.
View Article and Find Full Text PDF